DiScipio R G
Department of Immunology, Research Institute of Scripps Clinic, La Jolla, California 92037.
J Biol Chem. 1992 Aug 25;267(24):17087-94.
The formation and structure of the complement cytolytic intermediary complex, C5b-7, were studied with the aim of determining the interactive regions of C5, C6, and C7. The structure of human complement component C5 was elucidated by the application of limited proteolysis which generated well characterized major polypeptide fragments of this molecule. Plasmin, thrombin, and kallikrein cleave C5b with greater facility than C5. The most useful cleavage of C5b was effected by plasmin because the fragmentation pattern was similar to the processing of C3b by factors H, I, and kallikrein. Plasmin hydrolyzes peptide bonds within the alpha'-chain of C5b, resulting in a four-chain fragment, C5c (M(r) = 142,000), and a single chain fragment, C5d (M(r) = 43,000). Circular dichroism spectroscopic analyses indicated that C5d is substantially richer in alpha-helical content than is C5c (27 versus 9%). Polyclonal antibodies directed against C5c blocked the interaction of C5b-6 with C7, whereas antibodies directed against C5d inhibited the binding of C5 with C3b. Chemical cross-linking using a cleavable radioiodinated photoreactive reagent revealed that both C6 and C7 associate preferentially with the alpha'-chain of C5b. The reversible interactions of C5 with C6, C7, and major polypeptide fragments derived from these were investigated with solid phase binding assays. The results indicate that the carboxyl-terminal domains of C6 and C7, which have cysteine-rich modules homologous to those found in factors H and I, have the capacity to link specifically with C5.
为了确定补体C5、C6和C7的相互作用区域,对补体溶细胞中间复合物C5b - 7的形成和结构进行了研究。通过有限蛋白酶解的方法阐明了人补体成分C5的结构,该方法产生了该分子特征明确的主要多肽片段。纤溶酶、凝血酶和激肽释放酶对C5b的切割比C5更容易。对C5b最有效的切割是由纤溶酶完成的,因为其片段化模式与C3b被因子H、I和激肽释放酶处理的模式相似。纤溶酶水解C5b α'-链内的肽键,产生一个四链片段C5c(相对分子质量= 142,000)和一个单链片段C5d(相对分子质量= 43,000)。圆二色光谱分析表明,C5d的α-螺旋含量比C5c丰富得多(分别为27%和9%)。针对C5c的多克隆抗体阻断了C5b - 6与C7的相互作用,而针对C5d的抗体则抑制了C5与C3b的结合。使用可裂解的放射性碘化光反应试剂进行化学交联显示,C6和C7都优先与C5b的α'-链结合。通过固相结合试验研究了C5与C6、C7以及源自它们的主要多肽片段之间的可逆相互作用。结果表明,C6和C7的羧基末端结构域具有与因子H和I中富含半胱氨酸的模块同源的结构,能够与C5特异性结合。